Several studies have shown the oncogenic role of SOX11 in MCL pathogenesis by blocking B-cell differentiation, activating BCR signaling, and promoting angiogenesis and a protective tumor microenvironment with immune evasive mechanisms [9–14]. This evidence concerns the gene SOX11 and mantle cell lymphoma.